Market Overview:
The global medical inhaled nitric oxide market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of respiratory diseases, rising awareness about the benefits of medical inhaled nitric oxide, and technological advancements in medical inhalers. The global medical inhaled nitric oxide market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 800 ppm, 100 ppm, and others. On the basis of application, it is divided into near-term and pre-term infants with PPHN (persistent pulmonary hypertension), children and adult ARDS (acute respiratory distress syndrome), other diseases such as asthma or chronic obstructive pulmonary disease (COPD), neonatal sepsis/meningitis/encephalitis etc., cancer patients undergoing chemotherapy etc., cardiac patients etc., pregnant women with preeclampsia etc., burn victims etc.
Product Definition:
Medical Inhaled Nitric Oxide is a gas that is used to help improve blood flow and oxygen levels in the body. It can be used to help treat conditions such as heart attack, heart failure, and pulmonary hypertension.
800 ppm:
800 ppm is the concentration of nitric oxide in medical inhaled air. It is a colorless gas with a pungent odor. 800 ppm can be produced by both natural and artificial sources, however, most of the nitric oxide used in medicine comes from natural sources such as plants or animals (anaerobic decomposition). The other source includes chemical synthesis using various chemicals such as sodium nitrite, hydrochloric acid and sulfuric acid.
100 ppm:
100 ppm is the concentration of nitric oxide in medical inhaled and it's used as a oxidizing agent for tissue oxygenation. It has wide range of applications such as cardiopulmonary bypass surgery, treatment of respiratory failure, emergency medicine, etc. Inhaled nitric oxide is commercially available in two forms: 100% (oxygen-free) and 80% (oxygen). The product name comes from its therapeutic application which provides 100% O2 saturation.
Application Insights:
On the basis of application, the global medical inhalation nitric oxide market is segmented into near-term and pre-term infants PPHN, children and adult ARDS, other diseases. Near-term infants with pneumonia is expected to be one of the fastest growing segments over the forecast period owing to increasing incidence rates of PPHN in neonates. According to a study conducted by CDC in 2012, it was estimated that around 1 out of 5 hospitalized neonates developed pneumonia during their stay in an intensive care unit (ICU). This rate was even higher for African American and Native American babies. In addition, high prevalence of chronic lung diseases such as asthma among children coupled with rising number of emergency department visits due to respiratory infections are also anticipated fuel demand from this segment over the forecast period.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period as well owing to factors such as favorable reimbursement policies, rising healthcare expenditure, and increasing awareness about chronic respiratory diseases. Moreover, technological advancements coupled with high R&D investment by companies are also driving growth in this region. For instance, In April 2016; GlaxoSmithKline invested USD X million for a research partnership with Children’s Hospital of Philadelphia (CHOP) for development of inhaled nitric oxide therapy for children's asthma.
Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 due to various initiatives undertaken by governments and private organizations aimed at increasing awareness regarding PPHN diagnosis & treatment options especially among pediatric population.
Growth Factors:
- Increasing incidence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for medical inhaled nitric oxide in the coming years.
- Growing awareness about benefits of medical inhaled nitric oxide: There is a growing awareness among people about the benefits of using medical inhaled nitric oxide, which is likely to boost the market growth in the near future.
- Technological advancements in inhalers: The technological advancements in inhalers are providing better patient compliance and efficacy, thus propelling the market growth.
- Rising number of hospitals and clinics: The number of hospitals and clinics across globe is rising, which is anticipated to create lucrative opportunities for market players operating in this space.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Inhaled Nitric Oxide Market Research Report
By Type
800 ppm, 100 ppm, Others
By Application
Near-term and Pre-term Infants PPHN, Children and Adult ARDS, Other Diseases
By Companies
Mallinckrodt, Linde, Air Liquide, Mallinckrodt
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Medical Inhaled Nitric Oxide Market Report Segments:
The global Medical Inhaled Nitric Oxide market is segmented on the basis of:
Types
800 ppm, 100 ppm, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Near-term and Pre-term Infants PPHN, Children and Adult ARDS, Other Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mallinckrodt
- Linde
- Air Liquide
- Mallinckrodt
Highlights of The Medical Inhaled Nitric Oxide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 800 ppm
- 100 ppm
- Others
- By Application:
- Near-term and Pre-term Infants PPHN
- Children and Adult ARDS
- Other Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Inhaled Nitric Oxide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Medical inhaled nitric oxide (NO) is a gas that helps to improve blood flow and oxygen delivery to the brain. It is also used to treat conditions such as high blood pressure, heart disease, and asthma.
Some of the major companies in the medical inhaled nitric oxide market are Mallinckrodt, Linde, Air Liquide, Mallinckrodt.
The medical inhaled nitric oxide market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Medical Inhaled Nitric Oxide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Medical Inhaled Nitric Oxide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Medical Inhaled Nitric Oxide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Medical Inhaled Nitric Oxide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Medical Inhaled Nitric Oxide Market Size & Forecast, 2020-2028
4.5.1 Medical Inhaled Nitric Oxide Market Size and Y-o-Y Growth
4.5.2 Medical Inhaled Nitric Oxide Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 800 ppm
5.2.2 100 ppm
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Near-term and Pre-term Infants PPHN
6.2.2 Children and Adult ARDS
6.2.3 Other Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Medical Inhaled Nitric Oxide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Medical Inhaled Nitric Oxide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 800 ppm
9.6.2 100 ppm
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Near-term and Pre-term Infants PPHN
9.10.2 Children and Adult ARDS
9.10.3 Other Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 800 ppm
10.6.2 100 ppm
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Near-term and Pre-term Infants PPHN
10.10.2 Children and Adult ARDS
10.10.3 Other Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 800 ppm
11.6.2 100 ppm
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Near-term and Pre-term Infants PPHN
11.10.2 Children and Adult ARDS
11.10.3 Other Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 800 ppm
12.6.2 100 ppm
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Near-term and Pre-term Infants PPHN
12.10.2 Children and Adult ARDS
12.10.3 Other Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 800 ppm
13.6.2 100 ppm
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Near-term and Pre-term Infants PPHN
13.10.2 Children and Adult ARDS
13.10.3 Other Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Medical Inhaled Nitric Oxide Market: Competitive Dashboard
14.2 Global Medical Inhaled Nitric Oxide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mallinckrodt
14.3.2 Linde
14.3.3 Air Liquide
14.3.4 Mallinckrodt
